Kringle Pharma, Inc. (TYO:4884)
Japan · Delayed Price · Currency is JPY 305.00
+8.00 (2.69%)
Jun 24, 2026, 3:30 PM JST
Kringle Pharma Market Cap
Kringle Pharma has a market cap or net worth of 2.2 billion as of June 24, 2026. Its market cap has decreased by -62.34% in one year.
Market Cap
2.20B
Enterprise Value
608.32M
Revenue
73.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
305.00
Market Cap Chart
Since December 28, 2020, Kringle Pharma's market cap has decreased from 5.09B to 2.20B, a decrease of -56.82%. That is a compound annual growth rate of -14.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 2.20B | -22.25% |
| Dec 30, 2025 | 2.82B | -52.49% |
| Dec 30, 2024 | 5.95B | 30.66% |
| Dec 29, 2023 | 4.55B | 47.85% |
| Dec 30, 2022 | 3.08B | -0.04% |
| Dec 30, 2021 | 3.08B | -45.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chiome Bioscience | 5.05B |
| Kohjin Bio | 4.99B |
| PRISM BioLab Co.,LTD | 4.77B |
| Linical | 4.70B |
| TMS Co., Ltd. | 4.60B |
| D. Western Therapeutics Institute | 3.85B |
| Transgenic Group | 3.46B |
| Ribomic | 3.30B |